GSK3494245 / GSK  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GSK3494245 / GSK
NCT04504435: Safety, Tolerability and Pharmacokinetics (PK) Investigation of GSK3494245 in Healthy Participants

Completed
1
59
Europe
GSK3494245, Placebo
GlaxoSmithKline
Leishmaniasis
01/24
01/24

Download Options